A new preclinical study from scientists at Scripps Research suggests that an existing drug, already approved for treating ...

Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...

Over 1,000 pounds of trash found at Lake Tahoe after Fourth of July weekend A Vermont dairy farm was raided. The mixed ...

Alpine’s Formula 1 team boss has resigned, Jack Doohan’s been demoted with immediate effect, and his replacement Franco Colapinto’s only got a five-race guarantee.

FY25 adjusted EPS is forecast at €7.36, rising to €9.74 in FY26 and €12.70 in FY27. UCB’s adjusted EBITDA margin is expected to grow from 30% in FY25 to nearly 40% by 2030, driven by Bimzelx and four ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) ('VYNE” or the 'Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

Upadacitinib (Rinvoq, Abbvie) is a systemic anti-inflammatory drug approved by the FDA for treatment of 10 immune-mediated inflammatory disorders, including AD, rheumatoid arthritis, psoriatic ...